WDR4 and hepatocellular carcinoma: Finally, we observed that the use of sorafenib and WDR4 inhibitors had a more pronounced inhibitory effect on HCC than the use of sorafenib alone in both sorafenib-resistant or normal HCC cells (Fig. 3E).